David Maybee

Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial

Dave Singh, Christopher E. Brightling, Klaus F. Rabe et al. · The Lancet Respiratory Medicine · 2024 · 64 citations · Full text

Medicine, Internal Medicine, Pharmacology +10

SEVERE CANDIDIASIS ASSOCIATED WITH THYMIC DYSPLASIA, IgA DEFICIENCY, AND PLASMA ANTILYMPHOCYTE EFFECTS

Robert J. Schlegel, George M. Bernier, Joseph A. Bellanti et al. · PEDIATRICS · 1970 · 55 citations

Life Sciences, Immunology, Infectious Diseases +17

Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission

George R. Buchanan, Gaston K. Rivera, Brad H. Pollock et al. · Cancer · 2000 · 40 citations

Medicine, Oncology, Pharmacotherapy +17

Persistent catheter-related bacteremia: Clearance with antibiotics and urokinase

David P. Ascher, Braden A. Shoupe, David Maybee et al. · Journal of Pediatric Surgery · 1993 · 38 citations

Life Sciences, Infectious Diseases, Microbiology +12

Molecular evidence that childhood monosomy 7 syndrome is distinct from juvenile chronic myelogenous leukemia and other childhood myeloproliferative disorders

Mark Butcher, Robert W. Frenck, John Emperor et al. · Genes Chromosomes and Cancer · 1995 · 25 citations

Life Sciences, Genetics, Hematology +13